Clover Health (CLOV) CEO Jamie L. Reynoso Sells 2,360 Shares

What Happened
Jamie L. Reynoso, CEO (Medicare Advantage) of Clover Health Investments, sold 2,360 shares on 2026-06-17 in an open-market disposition. The weighted average sale price reported was $4.78 per share, for total proceeds of approximately $11,281. This was a sale (not a purchase or option exercise).

Key Details

• Transaction date: 2026-06-17 (reported on Form 4 filed 2026-06-18). Filing appears timely.
• Transaction type/code: Sale (S) — open market or private sale.
• Shares sold: 2,360; weighted average price: $4.78; total proceeds ≈ $11,281.
• Price range: shares were sold in multiple transactions at prices from $4.73 to $4.87 (inclusive).
• Footnote: The sale was made under a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2026. The filer can provide a breakdown of shares sold at each separate price upon request.
• Shares owned after transaction: not provided in the supplied data.

Context
A sale under a 10b5-1 plan is typically a preplanned transaction and does not necessarily reflect the insider’s current view of the company. For retail investors, purchases are often viewed as stronger signals than routine sales; this filing documents a routine, planned disposition.